InMode to Present at Upcoming Investor Conferences

InMode Ltd. (Nasdaq: INMD), a prominent provider of innovative medical technologies, is set to participate in two key investor conferences in March 2026. The company's Chief Financial Officer, Yair Malca, will take part in the Barclays 28th Annual Global Healthcare Conference in Miami, FL, on March 11 at 12:30 PM EST. This presentation will take the form of an in-person fireside chat, moderated by Matt Miksic, a Senior Equity Analyst, and will also feature one-on-one meetings with investors.

Following this event, InMode's Chief Executive Officer Moshe Mizrahy, alongside Malca, will engage in a virtual fireside chat at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Scheduled for March 16 at 1:20 PM EST, this format allows for a convenient online access point for investors, with a chat moderated by Suraj Kalia, a Senior Equity Analyst.

InMode is recognized for its groundbreaking work in developing diverse medical technologies, particularly using advanced radiofrequency (RF) technology. The company’s products cater to various medical specialties, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology, supporting both innovative surgical procedures and enhancing existing treatments. Investors and stakeholders seeking more information about the company’s offerings and innovations can access details through InMode's official website.

The release also includes forward-looking statements regarding the company's anticipated performance, emphasizing the inherent uncertainties and risks involved. As a public entity, InMode aligns with federal securities laws, cautioning stakeholders against overly relying on these projections. The investor community is advised to consult InMode's recent filings for a comprehensive understanding of the associated risks and business outlook.

InMode Ltd. (Nasdaq: INMD) is poised to enhance its visibility and engagement with investors through its participation in the upcoming Barclays 28th Annual Global Healthcare Conference and the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. As a prominent player in the medical technology sector, InMode's innovative radiofrequency (RF) technologies in the fields of plastic surgery, gynecology, dermatology, and more, make it a company worth watching.

The timing of these conferences, occurring in March, provides an ideal platform for InMode to address current market dynamics and articulate its growth strategy to potential and existing investors. With Yair Malca, CFO, and Moshe Mizrahy, CEO, set to present, stakeholders can anticipate insights into InMode's operational performance and future directions. The in-person aspect of the Barclays conference, accompanied by one-on-one meetings, may allow for more meaningful interactions and the opportunity for investors to ask crucial questions.

Given InMode's robust product lineup and its focus on minimally invasive treatments, it positions itself favorably in a market increasingly leaning towards less invasive surgical options. However, investors should remain cognizant of the inherent risks as highlighted in the company's forward-looking statements. These include the potential for actual results to deviate from forecasts due to various uncertainties.

Looking ahead, if InMode successfully conveys a compelling narrative of innovation and growth during these conferences, it could lead to increased investor interest and a positive shift in market sentiment. On the flip side, any indications of challenges in meeting growth projections could exacerbate volatility in its stock. Therefore, investors should monitor these presentations closely, as they may provide crucial insights into InMode’s strategic direction and market outlook.